Ependymoma epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(→Age) |
||
| Line 14: | Line 14: | ||
===Age=== | ===Age=== | ||
* Their occurrence seems to peak at age 5 years and then again at age 34. | * Their occurrence seems to peak at age 5 years and then again at age 34. | ||
* Subependymoma usually affects people over 40 years of age | |||
===Gender=== | |||
* Subependymoma more often affects men than women. | |||
==References== | ==References== | ||
Revision as of 20:15, 10 September 2012
|
Ependymoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ependymoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Ependymoma epidemiology and demographics |
|
Risk calculators and risk factors for Ependymoma epidemiology and demographics |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
Prevalence
- Ependymomas make up about 5% of adult intracranial gliomas and up to 10% of childhood tumors of the central nervous system (CNS).
Age
- Their occurrence seems to peak at age 5 years and then again at age 34.
- Subependymoma usually affects people over 40 years of age
Gender
- Subependymoma more often affects men than women.